US: 2 Indian-origin men charged with insider trading with Pfizer Covid meds
Two Indian-origin people, including a former Pfizer employee, have been charged with insider trading by federal authorities for their scheme to reap illicit profits by trading on information about the results of a COVID-19 medicine's clinical trials by the pharmaceutical giant.